Biopsy May Not Be Needed to Treat Immune Checkpoint Inhibitor-Associated Hepatitis Biopsy May Not Be Needed to Treat Immune Checkpoint Inhibitor-Associated Hepatitis
In patients taking immune checkpoint inhibitors who developed moderate-to-severe liver injury, a biopsy delayed steroid initiation and was not associated with more rapid hepatitis resolution of hepatitis, an observational study shows.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Gastroenterology | Hematology | Hepatitis | Liver | Study | Urology & Nephrology